Please enable JavaScript to continue using this application.

Compare $ADMA vs $SLS | Chartloom

Compare

$ADMA vs $SLS

ADMA Biologics Inc · Sellas Life Sciences Group Inc

ADMA

ADMA Biologics Inc

SLS

Sellas Life Sciences Group Inc

Compare $ADMA vs $SLS

Comparing ADMA Biologics Inc and Sellas Life Sciences Group Inc

ADMAADMA Biologics Inc

SLSSellas Life Sciences Group Inc

ADMAADMA Biologics Inc

Market cap

$2.40B

P/E (TTM)

14.12x

Forward P/E (NTM)

12.78x

Forward P/S (NTM)

4.05x

Rev growth (TTM)

8.0%

YTD performance

-42.1%

52W performance

-29.1%

FCF yield

4.8%

SLSSellas Life Sciences Group Inc

Market cap

$2.29B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

167.8%

52W performance

503.6%

FCF yield

-1.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ADMA

SLS

Detailed metrics comparison

ADMA

ADMA Biologics Inc

SLS

Sellas Life Sciences Group Inc

Market Cap

ADMA$2.40B

SLS$2.29B

Enterprise Value

ADMA$2.46B

SLS$2.15B

Price

ADMA$10.36

SLS$11.65

P/E Ratio

ADMA14.12x

SLSN/A

P/S Ratio

ADMA4.69x

SLS817.53x

EV/Sales

ADMA4.81x

SLS769.83x

EV/EBITDA

ADMA11.39x

SLS0.00x

P/B Ratio

ADMA5.33x

SLS17.22x

P/FCF Ratio

ADMA20.66x

SLSN/A

EV/FCF

ADMA21.18x

SLS-75.73x

PEG Ratio

ADMAN/A

SLSN/A

Forward P/E (NTM)

ADMA12.78x

SLSN/A

Forward P/S (NTM)

ADMA4.05x

SLSN/A

Revenue (TTM)

ADMA$512M

SLS$0

Revenue Growth (YoY)

ADMA8.0%

SLSN/A

Forward Rev Growth

ADMA17.6%

SLS144.9%

Gross Margin (TTM)

ADMA64.7%

SLS93.1%

Operating Margin (TTM)

ADMA43.4%

SLS0.0%

EBITDA Margin (TTM)

ADMA42.2%

SLS0.0%

Net Margin (TTM)

ADMA33.0%

SLS0.0%

FCF Margin (TTM)

ADMA22.7%

SLSN/A

Net Income (TTM)

ADMA$169M

SLS$-32M

FCF (TTM)

ADMA$116M

SLS$-28M

EPS (TTM)

ADMA$0.73

SLS-$0.17

ROE (TTM)

ADMA39.6%

SLS-3591.0%

ROA (TTM)

ADMA26.6%

SLS-3334.0%

ROIC (TTM)

ADMA30.1%

SLS-3591.0%

Cash

ADMA$136M

SLS$138M

Debt

ADMA$197M

SLS$0

Net Cash/Debt

ADMA$-61M

SLS$138M

Current Ratio (TTM)

ADMA6.97x

SLS18.83x

Quick Ratio (TTM)

ADMA3.62x

SLS18.29x

Debt/Equity (TTM)

ADMA0.48x

SLS0.00x

Debt/Assets (TTM)

ADMA0.0%

SLS0.0%

Interest Coverage (TTM)

ADMAN/A

SLSN/A

Net Debt/EBITDA (TTM)

ADMA0.00x

SLS0.00x

Beta

ADMA0.70

SLS2.68

52W Performance

ADMA-29.1%

SLS503.6%

YTD Performance

ADMA-42.1%

SLS167.8%

% from 52W High

ADMA-49.4%

SLS-26.6%

% from 52W Low

ADMA43.7%

SLS738.1%

Asset Turnover (TTM)

ADMA0.81x

SLS0.09x

FCF Yield (TTM)

ADMA4.8%

SLS-1.2%

Earnings Yield (TTM)

ADMA7.0%

SLS-1.4%

Dividend Yield (TTM)

ADMAN/A

SLSN/A

Rule of 40

ADMA30.7

SLS0.0

EV/GP/RG

ADMA0.47

SLSN/A

Ticker research

View ADMA research View SLS research

Metric	ADMA ADMA Biologics Inc	SLS Sellas Life Sciences Group Inc
Market & Valuation
Market Cap	$2.40B	$2.29B
Enterprise Value	$2.46B	$2.15B
Price	$10.36	$11.65
P/E Ratio	14.12x	N/A
P/S Ratio	4.69x	817.53x
EV/Sales	4.81x	769.83x
EV/EBITDA	11.39x	0.00x
P/B Ratio	5.33x	17.22x
P/FCF Ratio	20.66x	N/A
EV/FCF	21.18x	-75.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	12.78x	N/A
Forward P/S (NTM)	4.05x	N/A
Revenue & Growth
Revenue (TTM)	$512M	$0
Revenue Growth (YoY)	8.0%	N/A
Forward Rev Growth	17.6%	144.9%
Profitability
Gross Margin (TTM)	64.7%	93.1%
Operating Margin (TTM)	43.4%	0.0%
EBITDA Margin (TTM)	42.2%	0.0%
Net Margin (TTM)	33.0%	0.0%
FCF Margin (TTM)	22.7%	N/A
Net Income (TTM)	$169M	$-32M
FCF (TTM)	$116M	$-28M
EPS (TTM)	$0.73	-$0.17
ROE (TTM)	39.6%	-3591.0%
ROA (TTM)	26.6%	-3334.0%
ROIC (TTM)	30.1%	-3591.0%
Financial Health
Cash	$136M	$138M
Debt	$197M	$0
Net Cash/Debt	$-61M	$138M
Current Ratio (TTM)	6.97x	18.83x
Quick Ratio (TTM)	3.62x	18.29x
Debt/Equity (TTM)	0.48x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.70	2.68
52W Performance	-29.1%	503.6%
YTD Performance	-42.1%	167.8%
% from 52W High	-49.4%	-26.6%
% from 52W Low	43.7%	738.1%
Efficiency & Yields
Asset Turnover (TTM)	0.81x	0.09x
FCF Yield (TTM)	4.8%	-1.2%
Earnings Yield (TTM)	7.0%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	30.7	0.0
EV/GP/RG	0.47	N/A
Ticker research	View ADMA research	View SLS research

Valuation

P/E Ratio

ADMA

14.12x

P/S Ratio

ADMA

4.69x

SLS

817.53x

EV/FCF

SLS

-75.73x

ADMA

21.18x

Growth & revenue

Revenue Growth TTM

ADMA

8.0%

Forward Revenue Growth

SLS

144.9%

ADMA

17.6%

Profitability & performance

Gross Margin

SLS

93.1%

ADMA

64.7%

ROE

ADMA

39.6%

SLS

-3591.0%

FCF Yield %

ADMA

4.8%

SLS

-1.2%

52-Week Performance

SLS

503.6%

ADMA

-29.1%

Detailed metrics comparison

ADMA

ADMA Biologics Inc

SLS

Sellas Life Sciences Group Inc

Market Cap

ADMA$2.40B

SLS$2.29B

Enterprise Value

ADMA$2.46B

SLS$2.15B

Price

ADMA$10.36

SLS$11.65

P/E Ratio

ADMA14.12x

SLSN/A

P/S Ratio

ADMA4.69x

SLS817.53x

EV/Sales

ADMA4.81x

SLS769.83x

EV/EBITDA

ADMA11.39x

SLS0.00x

P/B Ratio

ADMA5.33x

SLS17.22x

P/FCF Ratio

ADMA20.66x

SLSN/A

EV/FCF

ADMA21.18x

SLS-75.73x

PEG Ratio

ADMAN/A

SLSN/A

Forward P/E (NTM)

ADMA12.78x

SLSN/A

Forward P/S (NTM)

ADMA4.05x

SLSN/A

Revenue (TTM)

ADMA$512M

SLS$0

Revenue Growth (YoY)

ADMA8.0%

SLSN/A

Forward Rev Growth

ADMA17.6%

SLS144.9%

Gross Margin (TTM)

ADMA64.7%

SLS93.1%

Operating Margin (TTM)

ADMA43.4%

SLS0.0%

EBITDA Margin (TTM)

ADMA42.2%

SLS0.0%

Net Margin (TTM)

ADMA33.0%

SLS0.0%

FCF Margin (TTM)

ADMA22.7%

SLSN/A

Net Income (TTM)

ADMA$169M

SLS$-32M

FCF (TTM)

ADMA$116M

SLS$-28M

EPS (TTM)

ADMA$0.73

SLS-$0.17

ROE (TTM)

ADMA39.6%

SLS-3591.0%

ROA (TTM)

ADMA26.6%

SLS-3334.0%

ROIC (TTM)

ADMA30.1%

SLS-3591.0%

Cash

ADMA$136M

SLS$138M

Debt

ADMA$197M

SLS$0

Net Cash/Debt

ADMA$-61M

SLS$138M

Current Ratio (TTM)

ADMA6.97x

SLS18.83x

Quick Ratio (TTM)

ADMA3.62x

SLS18.29x

Debt/Equity (TTM)

ADMA0.48x

SLS0.00x

Debt/Assets (TTM)

ADMA0.0%

SLS0.0%

Interest Coverage (TTM)

ADMAN/A

SLSN/A

Net Debt/EBITDA (TTM)

ADMA0.00x

SLS0.00x

Beta

ADMA0.70

SLS2.68

52W Performance

ADMA-29.1%

SLS503.6%

YTD Performance

ADMA-42.1%

SLS167.8%

% from 52W High

ADMA-49.4%

SLS-26.6%

% from 52W Low

ADMA43.7%

SLS738.1%

Asset Turnover (TTM)

ADMA0.81x

SLS0.09x

FCF Yield (TTM)

ADMA4.8%

SLS-1.2%

Earnings Yield (TTM)

ADMA7.0%

SLS-1.4%

Dividend Yield (TTM)

ADMAN/A

SLSN/A

Rule of 40

ADMA30.7

SLS0.0

EV/GP/RG

ADMA0.47

SLSN/A

Ticker research

View ADMA research View SLS research

Metric	ADMA ADMA Biologics Inc	SLS Sellas Life Sciences Group Inc
Market & Valuation
Market Cap	$2.40B	$2.29B
Enterprise Value	$2.46B	$2.15B
Price	$10.36	$11.65
P/E Ratio	14.12x	N/A
P/S Ratio	4.69x	817.53x
EV/Sales	4.81x	769.83x
EV/EBITDA	11.39x	0.00x
P/B Ratio	5.33x	17.22x
P/FCF Ratio	20.66x	N/A
EV/FCF	21.18x	-75.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	12.78x	N/A
Forward P/S (NTM)	4.05x	N/A
Revenue & Growth
Revenue (TTM)	$512M	$0
Revenue Growth (YoY)	8.0%	N/A
Forward Rev Growth	17.6%	144.9%
Profitability
Gross Margin (TTM)	64.7%	93.1%
Operating Margin (TTM)	43.4%	0.0%
EBITDA Margin (TTM)	42.2%	0.0%
Net Margin (TTM)	33.0%	0.0%
FCF Margin (TTM)	22.7%	N/A
Net Income (TTM)	$169M	$-32M
FCF (TTM)	$116M	$-28M
EPS (TTM)	$0.73	-$0.17
ROE (TTM)	39.6%	-3591.0%
ROA (TTM)	26.6%	-3334.0%
ROIC (TTM)	30.1%	-3591.0%
Financial Health
Cash	$136M	$138M
Debt	$197M	$0
Net Cash/Debt	$-61M	$138M
Current Ratio (TTM)	6.97x	18.83x
Quick Ratio (TTM)	3.62x	18.29x
Debt/Equity (TTM)	0.48x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.70	2.68
52W Performance	-29.1%	503.6%
YTD Performance	-42.1%	167.8%
% from 52W High	-49.4%	-26.6%
% from 52W Low	43.7%	738.1%
Efficiency & Yields
Asset Turnover (TTM)	0.81x	0.09x
FCF Yield (TTM)	4.8%	-1.2%
Earnings Yield (TTM)	7.0%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	30.7	0.0
EV/GP/RG	0.47	N/A
Ticker research	View ADMA research	View SLS research